PALIPERIDONE
NDC 43975-351, PALIPERIDONE, tablet, extended release, from ANI Pharmaceuticals, Inc..
- Product NDC
- 43975-351
- Status
- Listed
- Labeler
- ANI Pharmaceuticals, Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204452
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43975-351 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PALIPERIDONE6 mg/1
Pharmacologic classes
Atypical Antipsychotic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43975-351-03 | 43975035103 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43975-351-03) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/bbbaa057-f587-4eb9-a0d2-463dbcd57661NADAC price for package 43975035103
GET /v1/drugs/nadac/43975035103
Use it
Look up 43975-351 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43975-351 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43975-351. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.